After selling a significant stake to Singapore-based Temasek, Dr Ranjan Pai, chairman, Manipal Group, says he would not want to dilute his stake below 30 per cent. Speaking to Sohini Das and Dev Chatterjee, Pai confirms that going forward Manipal Health will look for a listing. Edited excerpts.
Why did you choose Temasek over others?
We have always wanted to have a long-term partner in health care. Most private equities have a 4-5 year window. Temasek was looking at a long-term investment in India, and this is what excited us. This isn't like a traditional investment from private equity. We were also looking for an exit for TPG, and that’s how the conversation started. We had some debt in the holding company which we wanted to pare. We thought this could be one way to look at it – we take care of our debt, we have a long-term partner. They have been with us for the
TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.
Subscribe To Insights
Key stories on business-standard.com are available to premium subscribers only.Already a BS Premium subscriber? Log in NOW
Or